You should contact your healthcare provider if: You are currently taking a GLP-1 medication and discover you are pregnant or planning to breastfeed : Early discussion allows time to transition to safer alternatives before delivery
What Some Of The Evidence Shows So Far The SURMOUNT 1 study has highlighted the effectiveness of tirzepatide in managing overweight and obesity long term
Provider involvement after sign-up is also limited, even by telehealth standards, which is why safety lands at a B rather than higher
Natural GLP-1 receptor agonist: The kingdom of plants has great promise for the development of novel medications to treat a range of conditions, including diabetes mellitus
I congratulate the communities of scientists and patients who participated in the treatment trials to make approved therapy for MASH a reality. Rezdiffra is expected to be available for patients starting in April 2024
Your doctor will check your medical history, do a physical exam, and order lab tests
